1 Market Overview

1.1 Product Overview and Scope of Cell and Gene Therapy

1.2 Classification of Cell and Gene Therapy by Type

1.2.1 Overview: Global Cell and Gene Therapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Cell and Gene Therapy Revenue Market Share by Type in 2020

1.2.3 Rare Diseases

1.2.4 Oncology

1.2.5 Hematology

1.2.6 Cardiovascular

1.2.7 Ophthalmology

1.2.8 Neurology

1.2.9 Other Therapeutic Classes

1.3 Global Cell and Gene Therapy Market by Application

1.3.1 Overview: Global Cell and Gene Therapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Research and Academic Institutions

1.3.4 Contract Research Organizations (CROs)

1.3.5 Hospital

1.3.6 Others

1.4 Global Cell and Gene Therapy Market Size & Forecast

1.5 Global Cell and Gene Therapy Market Size and Forecast by Region

1.5.1 Global Cell and Gene Therapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Cell and Gene Therapy Market Size by Region, (2016-2021)

1.5.3 North America Cell and Gene Therapy Market Size and Prospect (2016-2026)

1.5.4 Europe Cell and Gene Therapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Cell and Gene Therapy Market Size and Prospect (2016-2026)

1.5.6 South America Cell and Gene Therapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Cell and Gene Therapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Cell and Gene Therapy Market Drivers

1.6.2 Cell and Gene Therapy Market Restraints

1.6.3 Cell and Gene Therapy Trends Analysis

2 Company Profiles

2.1 Amgen Inc.

2.1.1 Amgen Inc. Details

2.1.2 Amgen Inc. Major Business

2.1.3 Amgen Inc. Cell and Gene Therapy Product and Solutions

2.1.4 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Amgen Inc. Recent Developments and Future Plans

2.2 bluebird bio, Inc.

2.2.1 bluebird bio, Inc. Details

2.2.2 bluebird bio, Inc. Major Business

2.2.3 bluebird bio, Inc. Cell and Gene Therapy Product and Solutions

2.2.4 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 bluebird bio, Inc. Recent Developments and Future Plans

2.3 Dendreon Pharmaceuticals LLC.

2.3.1 Dendreon Pharmaceuticals LLC. Details

2.3.2 Dendreon Pharmaceuticals LLC. Major Business

2.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Solutions

2.3.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans

2.4 Fibrocell Science, Inc.

2.4.1 Fibrocell Science, Inc. Details

2.4.2 Fibrocell Science, Inc. Major Business

2.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Product and Solutions

2.4.4 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Fibrocell Science, Inc. Recent Developments and Future Plans

2.5 Human Stem Cells Institute

2.5.1 Human Stem Cells Institute Details

2.5.2 Human Stem Cells Institute Major Business

2.5.3 Human Stem Cells Institute Cell and Gene Therapy Product and Solutions

2.5.4 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Human Stem Cells Institute Recent Developments and Future Plans

2.6 Kite Pharma, Inc.

2.6.1 Kite Pharma, Inc. Details

2.6.2 Kite Pharma, Inc. Major Business

2.6.3 Kite Pharma, Inc. Cell and Gene Therapy Product and Solutions

2.6.4 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Kite Pharma, Inc. Recent Developments and Future Plans

2.7 Kolon TissueGene, Inc.

2.7.1 Kolon TissueGene, Inc. Details

2.7.2 Kolon TissueGene, Inc. Major Business

2.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Product and Solutions

2.7.4 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Kolon TissueGene, Inc. Recent Developments and Future Plans

2.8 Novartis AG

2.8.1 Novartis AG Details

2.8.2 Novartis AG Major Business

2.8.3 Novartis AG Cell and Gene Therapy Product and Solutions

2.8.4 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Novartis AG Recent Developments and Future Plans

2.9 Orchard Therapeutics plc.

2.9.1 Orchard Therapeutics plc. Details

2.9.2 Orchard Therapeutics plc. Major Business

2.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Product and Solutions

2.9.4 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Orchard Therapeutics plc. Recent Developments and Future Plans

2.10 Organogenesis Holdings Inc.

2.10.1 Organogenesis Holdings Inc. Details

2.10.2 Organogenesis Holdings Inc. Major Business

2.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Product and Solutions

2.10.4 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Organogenesis Holdings Inc. Recent Developments and Future Plans

2.11 Pfizer, Inc.

2.11.1 Pfizer, Inc. Details

2.11.2 Pfizer, Inc. Major Business

2.11.3 Pfizer, Inc. Cell and Gene Therapy Product and Solutions

2.11.4 Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Pfizer, Inc. Recent Developments and Future Plans

2.12 RENOVA THERAPEUTICS

2.12.1 RENOVA THERAPEUTICS Details

2.12.2 RENOVA THERAPEUTICS Major Business

2.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Product and Solutions

2.12.4 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 RENOVA THERAPEUTICS Recent Developments and Future Plans

2.13 Shanghai Sunway Biotech Co., Ltd.,

2.13.1 Shanghai Sunway Biotech Co., Ltd., Details

2.13.2 Shanghai Sunway Biotech Co., Ltd., Major Business

2.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product and Solutions

2.13.4 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Developments and Future Plans

2.14 Sibiono GeneTech Co. Ltd.,

2.14.1 Sibiono GeneTech Co. Ltd., Details

2.14.2 Sibiono GeneTech Co. Ltd., Major Business

2.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product and Solutions

2.14.4 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Sibiono GeneTech Co. Ltd., Recent Developments and Future Plans

2.15 Spark Therapeutics, Inc.

2.15.1 Spark Therapeutics, Inc. Details

2.15.2 Spark Therapeutics, Inc. Major Business

2.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Product and Solutions

2.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Spark Therapeutics, Inc. Recent Developments and Future Plans

2.16 Vericel Corporation

2.16.1 Vericel Corporation Details

2.16.2 Vericel Corporation Major Business

2.16.3 Vericel Corporation Cell and Gene Therapy Product and Solutions

2.16.4 Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Vericel Corporation Recent Developments and Future Plans

2.17 ViroMed Co., Ltd.

2.17.1 ViroMed Co., Ltd. Details

2.17.2 ViroMed Co., Ltd. Major Business

2.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Product and Solutions

2.17.4 ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 ViroMed Co., Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Cell and Gene Therapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Cell and Gene Therapy Players Market Share

3.2.2 Top 10 Cell and Gene Therapy Players Market Share

3.2.3 Market Competition Trend

3.3 Cell and Gene Therapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Cell and Gene Therapy Revenue and Market Share by Type (2016-2021)

4.2 Global Cell and Gene Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Cell and Gene Therapy Revenue Market Share by Application (2016-2021)

5.2 Cell and Gene Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Cell and Gene Therapy Revenue by Type (2016-2026)

6.2 North America Cell and Gene Therapy Revenue by Application (2016-2026)

6.3 North America Cell and Gene Therapy Market Size by Country

6.3.1 North America Cell and Gene Therapy Revenue by Country (2016-2026)

6.3.2 United States Cell and Gene Therapy Market Size and Forecast (2016-2026)

6.3.3 Canada Cell and Gene Therapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Cell and Gene Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Cell and Gene Therapy Revenue by Type (2016-2026)

7.2 Europe Cell and Gene Therapy Revenue by Application (2016-2026)

7.3 Europe Cell and Gene Therapy Market Size by Country

7.3.1 Europe Cell and Gene Therapy Revenue by Country (2016-2026)

7.3.2 Germany Cell and Gene Therapy Market Size and Forecast (2016-2026)

7.3.3 France Cell and Gene Therapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Cell and Gene Therapy Market Size and Forecast (2016-2026)

7.3.5 Russia Cell and Gene Therapy Market Size and Forecast (2016-2026)

7.3.6 Italy Cell and Gene Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Cell and Gene Therapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Cell and Gene Therapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Cell and Gene Therapy Market Size by Region

8.3.1 Asia-Pacific Cell and Gene Therapy Revenue by Region (2016-2026)

8.3.2 China Cell and Gene Therapy Market Size and Forecast (2016-2026)

8.3.3 Japan Cell and Gene Therapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Cell and Gene Therapy Market Size and Forecast (2016-2026)

8.3.5 India Cell and Gene Therapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Cell and Gene Therapy Market Size and Forecast (2016-2026)

8.3.7 Australia Cell and Gene Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Cell and Gene Therapy Revenue by Type (2016-2026)

9.2 South America Cell and Gene Therapy Revenue by Application (2016-2026)

9.3 South America Cell and Gene Therapy Market Size by Country

9.3.1 South America Cell and Gene Therapy Revenue by Country (2016-2026)

9.3.2 Brazil Cell and Gene Therapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Cell and Gene Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Cell and Gene Therapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Cell and Gene Therapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Cell and Gene Therapy Market Size by Country

10.3.1 Middle East & Africa Cell and Gene Therapy Revenue by Country (2016-2026)

10.3.2 Turkey Cell and Gene Therapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Cell and Gene Therapy Market Size and Forecast (2016-2026)

10.3.4 UAE Cell and Gene Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Cell and Gene Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Cell and Gene Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Cell and Gene Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Cell and Gene Therapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Cell and Gene Therapy Revenue Market Share by Region (2021-2026)

Table 6. Amgen Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Amgen Inc. Major Business

Table 8. Amgen Inc. Cell and Gene Therapy Product and Solutions

Table 9. Amgen Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. bluebird bio, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. bluebird bio, Inc. Major Business

Table 12. bluebird bio, Inc. Cell and Gene Therapy Product and Solutions

Table 13. bluebird bio, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Dendreon Pharmaceuticals LLC. Corporate Information, Head Office, and Major Competitors

Table 15. Dendreon Pharmaceuticals LLC. Major Business

Table 16. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Solutions

Table 17. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Fibrocell Science, Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Fibrocell Science, Inc. Major Business

Table 20. Fibrocell Science, Inc. Cell and Gene Therapy Product and Solutions

Table 21. Fibrocell Science, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Human Stem Cells Institute Corporate Information, Head Office, and Major Competitors

Table 23. Human Stem Cells Institute Major Business

Table 24. Human Stem Cells Institute Cell and Gene Therapy Product and Solutions

Table 25. Human Stem Cells Institute Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Kite Pharma, Inc. Corporate Information, Head Office, and Major Competitors

Table 27. Kite Pharma, Inc. Major Business

Table 28. Kite Pharma, Inc. Cell and Gene Therapy Product and Solutions

Table 29. Kite Pharma, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Kolon TissueGene, Inc. Corporate Information, Head Office, and Major Competitors

Table 31. Kolon TissueGene, Inc. Major Business

Table 32. Kolon TissueGene, Inc. Cell and Gene Therapy Product and Solutions

Table 33. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Novartis AG Corporate Information, Head Office, and Major Competitors

Table 35. Novartis AG Major Business

Table 36. Novartis AG Cell and Gene Therapy Product and Solutions

Table 37. Novartis AG Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Orchard Therapeutics plc. Corporate Information, Head Office, and Major Competitors

Table 39. Orchard Therapeutics plc. Major Business

Table 40. Orchard Therapeutics plc. Cell and Gene Therapy Product and Solutions

Table 41. Orchard Therapeutics plc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Organogenesis Holdings Inc. Corporate Information, Head Office, and Major Competitors

Table 43. Organogenesis Holdings Inc. Major Business

Table 44. Organogenesis Holdings Inc. Cell and Gene Therapy Product and Solutions

Table 45. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Pfizer, Inc. Corporate Information, Head Office, and Major Competitors

Table 47. Pfizer, Inc. Major Business

Table 48. Pfizer, Inc. Cell and Gene Therapy Product and Solutions

Table 49. Pfizer, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. RENOVA THERAPEUTICS Corporate Information, Head Office, and Major Competitors

Table 51. RENOVA THERAPEUTICS Major Business

Table 52. RENOVA THERAPEUTICS Cell and Gene Therapy Product and Solutions

Table 53. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Shanghai Sunway Biotech Co., Ltd., Corporate Information, Head Office, and Major Competitors

Table 55. Shanghai Sunway Biotech Co., Ltd., Major Business

Table 56. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product and Solutions

Table 57. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Sibiono GeneTech Co. Ltd., Corporate Information, Head Office, and Major Competitors

Table 59. Sibiono GeneTech Co. Ltd., Major Business

Table 60. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product and Solutions

Table 61. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Spark Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Spark Therapeutics, Inc. Major Business

Table 64. Spark Therapeutics, Inc. Cell and Gene Therapy Product and Solutions

Table 65. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Vericel Corporation Corporate Information, Head Office, and Major Competitors

Table 67. Vericel Corporation Major Business

Table 68. Vericel Corporation Cell and Gene Therapy Product and Solutions

Table 69. Vericel Corporation Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. ViroMed Co., Ltd. Corporate Information, Head Office, and Major Competitors

Table 71. ViroMed Co., Ltd. Major Business

Table 72. ViroMed Co., Ltd. Cell and Gene Therapy Product and Solutions

Table 73. ViroMed Co., Ltd. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Global Cell and Gene Therapy Revenue (USD Million) by Players (2019-2021)

Table 75. Global Cell and Gene Therapy Revenue Share by Players (2019-2021)

Table 76. Breakdown of Cell and Gene Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Cell and Gene Therapy Players Head Office, Products and Services Provided

Table 78. Cell and Gene Therapy Mergers & Acquisitions in the Past Five Years

Table 79. Cell and Gene Therapy New Entrants and Expansion Plans

Table 80. Global Cell and Gene Therapy Revenue (USD Million) by Type (2016-2021)

Table 81. Global Cell and Gene Therapy Revenue Share by Type (2016-2021)

Table 82. Global Cell and Gene Therapy Revenue Forecast by Type (2021-2026)

Table 83. Global Cell and Gene Therapy Revenue by Application (2016-2021)

Table 84. Global Cell and Gene Therapy Revenue Forecast by Application (2021-2026)

Table 85. North America Cell and Gene Therapy Revenue by Type (2016-2021) & (USD Million)

Table 86. North America Cell and Gene Therapy Revenue by Type (2021-2026) & (USD Million)

Table 87. North America Cell and Gene Therapy Revenue by Application (2016-2021) & (USD Million)

Table 88. North America Cell and Gene Therapy Revenue by Application (2021-2026) & (USD Million)

Table 89. North America Cell and Gene Therapy Revenue by Country (2016-2021) & (USD Million)

Table 90. North America Cell and Gene Therapy Revenue by Country (2021-2026) & (USD Million)

Table 91. Europe Cell and Gene Therapy Revenue by Type (2016-2021) & (USD Million)

Table 92. Europe Cell and Gene Therapy Revenue by Type (2021-2026) & (USD Million)

Table 93. Europe Cell and Gene Therapy Revenue by Application (2016-2021) & (USD Million)

Table 94. Europe Cell and Gene Therapy Revenue by Application (2021-2026) & (USD Million)

Table 95. Europe Cell and Gene Therapy Revenue by Country (2016-2021) & (USD Million)

Table 96. Europe Cell and Gene Therapy Revenue by Country (2021-2026) & (USD Million)

Table 97. Asia-Pacific Cell and Gene Therapy Revenue by Type (2016-2021) & (USD Million)

Table 98. Asia-Pacific Cell and Gene Therapy Revenue by Type (2021-2026) & (USD Million)

Table 99. Asia-Pacific Cell and Gene Therapy Revenue by Application (2016-2021) & (USD Million)

Table 100. Asia-Pacific Cell and Gene Therapy Revenue by Application (2021-2026) & (USD Million)

Table 101. Asia-Pacific Cell and Gene Therapy Revenue by Region (2016-2021) & (USD Million)

Table 102. Asia-Pacific Cell and Gene Therapy Revenue by Region (2021-2026) & (USD Million)

Table 103. South America Cell and Gene Therapy Revenue by Type (2016-2021) & (USD Million)

Table 104. South America Cell and Gene Therapy Revenue by Type (2021-2026) & (USD Million)

Table 105. South America Cell and Gene Therapy Revenue by Application (2016-2021) & (USD Million)

Table 106. South America Cell and Gene Therapy Revenue by Application (2021-2026) & (USD Million)

Table 107. South America Cell and Gene Therapy Revenue by Country (2016-2021) & (USD Million)

Table 108. South America Cell and Gene Therapy Revenue by Country (2021-2026) & (USD Million)

Table 109. Middle East & Africa Cell and Gene Therapy Revenue by Type (2016-2021) & (USD Million)

Table 110. Middle East & Africa Cell and Gene Therapy Revenue by Type (2021-2026) & (USD Million)

Table 111. Middle East & Africa Cell and Gene Therapy Revenue by Application (2016-2021) & (USD Million)

Table 112. Middle East & Africa Cell and Gene Therapy Revenue by Application (2021-2026) & (USD Million)

Table 113. Middle East & Africa Cell and Gene Therapy Revenue by Country (2016-2021) & (USD Million)

Table 114. Middle East & Africa Cell and Gene Therapy Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Cell and Gene Therapy Picture

Figure 2. Global Cell and Gene Therapy Revenue Market Share by Type in 2020

Figure 3. Rare Diseases

Figure 4. Oncology

Figure 5. Hematology

Figure 6. Cardiovascular

Figure 7. Ophthalmology

Figure 8. Neurology

Figure 9. Other Therapeutic Classes

Figure 10. Cell and Gene Therapy Revenue Market Share by Application in 2020

Figure 11. Pharmaceutical and Biotechnology Companies Picture

Figure 12. Research and Academic Institutions Picture

Figure 13. Contract Research Organizations (CROs) Picture

Figure 14. Hospital Picture

Figure 15. Others Picture

Figure 16. Global Cell and Gene Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 17. Global Cell and Gene Therapy Revenue and Forecast (2016-2026) & (USD Million)

Figure 18. Global Cell and Gene Therapy Revenue Market Share by Region (2016-2026)

Figure 19. Global Cell and Gene Therapy Revenue Market Share by Region in 2020

Figure 20. North America Cell and Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Europe Cell and Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Asia-Pacific Cell and Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. South America Cell and Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Middle East and Africa Cell and Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 25. Cell and Gene Therapy Market Drivers

Figure 26. Cell and Gene Therapy Market Restraints

Figure 27. Cell and Gene Therapy Market Trends

Figure 28. Amgen Inc. Recent Developments and Future Plans

Figure 29. bluebird bio, Inc. Recent Developments and Future Plans

Figure 30. Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans

Figure 31. Fibrocell Science, Inc. Recent Developments and Future Plans

Figure 32. Human Stem Cells Institute Recent Developments and Future Plans

Figure 33. Kite Pharma, Inc. Recent Developments and Future Plans

Figure 34. Kolon TissueGene, Inc. Recent Developments and Future Plans

Figure 35. Novartis AG Recent Developments and Future Plans

Figure 36. Orchard Therapeutics plc. Recent Developments and Future Plans

Figure 37. Organogenesis Holdings Inc. Recent Developments and Future Plans

Figure 38. Pfizer, Inc. Recent Developments and Future Plans

Figure 39. RENOVA THERAPEUTICS Recent Developments and Future Plans

Figure 40. Shanghai Sunway Biotech Co., Ltd., Recent Developments and Future Plans

Figure 41. Sibiono GeneTech Co. Ltd., Recent Developments and Future Plans

Figure 42. Spark Therapeutics, Inc. Recent Developments and Future Plans

Figure 43. Vericel Corporation Recent Developments and Future Plans

Figure 44. ViroMed Co., Ltd. Recent Developments and Future Plans

Figure 45. Global Cell and Gene Therapy Revenue Share by Players in 2020

Figure 46. Cell and Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 47. Global Top 3 Players Cell and Gene Therapy Revenue Market Share in 2020

Figure 48. Global Top 10 Players Cell and Gene Therapy Revenue Market Share in 2020

Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 50. Global Cell and Gene Therapy Revenue Share by Type in 2020

Figure 51. Global Cell and Gene Therapy Market Share Forecast by Type (2021-2026)

Figure 52. Global Cell and Gene Therapy Revenue Share by Application in 2020

Figure 53. Global Cell and Gene Therapy Market Share Forecast by Application (2021-2026)

Figure 54. North America Cell and Gene Therapy Sales Market Share by Type (2016-2026)

Figure 55. North America Cell and Gene Therapy Sales Market Share by Application (2016-2026)

Figure 56. North America Cell and Gene Therapy Revenue Market Share by Country (2016-2026)

Figure 57. United States Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Canada Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Mexico Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Europe Cell and Gene Therapy Sales Market Share by Type (2016-2026)

Figure 61. Europe Cell and Gene Therapy Sales Market Share by Application (2016-2026)

Figure 62. Europe Cell and Gene Therapy Revenue Market Share by Country (2016-2026)

Figure 63. Germany Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. France Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. United Kingdom Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Russia Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Italy Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Asia-Pacific Cell and Gene Therapy Sales Market Share by Type (2016-2026)

Figure 69. Asia-Pacific Cell and Gene Therapy Sales Market Share by Application (2016-2026)

Figure 70. Asia-Pacific Cell and Gene Therapy Revenue Market Share by Region (2016-2026)

Figure 71. China Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Japan Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South Korea Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. India Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Southeast Asia Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Australia Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South America Cell and Gene Therapy Sales Market Share by Type (2016-2026)

Figure 78. South America Cell and Gene Therapy Sales Market Share by Application (2016-2026)

Figure 79. South America Cell and Gene Therapy Revenue Market Share by Country (2016-2026)

Figure 80. Brazil Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Argentina Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Middle East and Africa Cell and Gene Therapy Sales Market Share by Type (2016-2026)

Figure 83. Middle East and Africa Cell and Gene Therapy Sales Market Share by Application (2016-2026)

Figure 84. Middle East and Africa Cell and Gene Therapy Revenue Market Share by Country (2016-2026)

Figure 85. Turkey Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Saudi Arabia Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. UAE Cell and Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. Methodology

Figure 89. Research Process and Data Source